About the Authors

Fanny Comblain

Affiliation Bone and Cartilage Research Unit, Arthropôle Liège, University of Liège, CHU Sart-Tilman, Liège, Belgium

Jean-Emile Dubuc

Affiliation Orthopedic Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium

Cécile Lambert

Affiliation Bone and Cartilage Research Unit, Arthropôle Liège, University of Liège, CHU Sart-Tilman, Liège, Belgium

Christelle Sanchez

Affiliation Bone and Cartilage Research Unit, Arthropôle Liège, University of Liège, CHU Sart-Tilman, Liège, Belgium

Isabelle Lesponne

Affiliation Royal Canin Research Center, Aimargues, France

Samuel Serisier

Affiliation Royal Canin Research Center, Aimargues, France

Yves Henrotin

yhenrotin@ulg.ac.be

Affiliations Bone and Cartilage Research Unit, Arthropôle Liège, University of Liège, CHU Sart-Tilman, Liège, Belgium, Physical Therapy and Rehabilitation Department, Princess Paola Hospital, Vivalia, Marche-en-Famenne, Belgium

Competing Interests

FC received a PhD fellow from Royal Canin SAS. IL and SS are employed by Royal Canin SAS. YH received honoraria from Artialis, Bepharbel, Bioiberica, Expanscience, Galapagos, Ibsa, KiOmed Pharma and Tilman. YH is the founder and President of Artialis SA, a biomarker manufacturer and KiOmed Pharma, two spin-off companies of the University of Liege. FC, SS and YH are inventors for patent WO/2014/184246. Royal Canin developed a product thanks to these results. This did not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: FC IL SS YH. Performed the experiments: FC JED. Analyzed the data: FC CL CS IL SS YH. Contributed reagents/materials/analysis tools: JED IL SS. Wrote the paper: FC YH.